EPRS1通过增强T细胞增殖与活性驱动小管间质性肾炎纤维化
毒素或药物诱导的小管间质性肾炎(TIN)常因不可逆纤维化需透析,但缺乏调控间质免疫细胞的药物。本研究显示TIN后肾脏浸润EPRS1高表达T细胞,Eprs1+/-小鼠T细胞增殖及IL-17产生减少且纤维化减轻,EPRS1抑制剂bersiporocin可缓解免疫纤维化加重,人肾组织及血T细胞EPRS1高表达与不良预后相关。
要点
- TIN后肾脏浸润EPRS1高表达T细胞,尤其增殖性T细胞和γδ T细胞
- Eprs1+/-小鼠T细胞增殖及γδ T细胞IL-17产生减少,纤维化减轻
- EPRS1抑制剂bersiporocin可缓解TIN免疫纤维化加重
核心结论
- EPRS1通过增强浸润T细胞的增殖和活性驱动毒素或药物诱导的TIN纤维化,其药理抑制可减轻纤维化。
研究设计与样本
- 采用腺嘌呤混合饮食诱导TIN的小鼠模型,比较Eprs1+/+与Eprs1+/-小鼠及Rag1-/-过继转移T细胞的纤维化差异。
- 使用EPRS1靶向小分子抑制剂bersiporocin干预TIN小鼠,并检测人肾组织和血源性T细胞EPRS1表达与预后关联。
主要发现
- TIN诱导后肾脏浸润EPRS1高表达T细胞,尤其增殖性T细胞和γδ T细胞。
- Eprs1+/+小鼠肾脏CD4+和CD8+ T细胞增殖能力及γδ T细胞IL-17产生均高于Eprs1+/-小鼠。
- Eprs1+/-小鼠TIN诱导的纤维化减轻,Rag1-/-小鼠过继转移Eprs1+/- T细胞后纤维化也减少。
- bersiporocin减轻TIN的免疫纤维化加重。
- 人肾组织和血源性T细胞表达EPRS1,高表达与患者更差结局相关。
临床怎么用
- EPRS1可能作为毒素或药物诱导TIN的潜在治疗靶点,通过调控浸润T细胞增殖和活性减轻纤维化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Toxin- and drug-induced tubulointerstitial nephritis (TIN), characterized by interstitial infiltration of immune cells, frequently necessitates dialysis for patients due to irreversible fibrosis. However, agents modulating interstitial immune cells are lacking. Here, we addressed whether the housekeeping enzyme glutamyl-prolyl-transfer RNA synthetase 1 (EPRS1), responsible for attaching glutamic acid and proline to transfer RNA, modulates immune cell activity during TIN and whether its pharmacological inhibition abrogates fibrotic transformation. The immunological feature following TIN induction by means of an adenine-mixed diet was infiltration of EPRS1high T cells, particularly proliferating T and γδ T cells. The proliferation capacity of both CD4+ and CD8+ T cells, along with interleukin-17 production of γδ T cells, was higher in the kidneys of TIN-induced Eprs1+/+ mice than in the kidneys of TIN-induced Eprs1+/- mice. This discrepancy contributed to the fibrotic amelioration observed in kidneys of Eprs1+/- mice. TIN-induced fibrosis was also reduced in Rag1-/- mice adoptively transferred with Eprs1+/- T cells compared to the Rag1-/- mice transferred with Eprs1+/+ T cells. The use of an EPRS1-targeting small molecule inhibitor (bersiporocin) under clinical trials to evaluate its therapeutic potential against idiopathic pulmonary fibrosis alleviated immunofibrotic aggravation in TIN. EPRS1 expression was also observed in human kidney tissues and blood-derived T cells, and high expression was associated with worse patient outcomes. Thus, EPRS1 may emerge as a therapeutic target in toxin- and drug-induced TIN, modulating the proliferation and activity of infiltrated T cells.
引用
- Kang C, Yun D, Yoon H, et al. Glutamyl-prolyl-tRNA synthetase (EPRS1) drives tubulointerstitial nephritis-induced fibrosis by enhancing T cell proliferation and activity. Kidney Int. 2024. PMID: 38320721. doi:10.1016/j.kint.2024.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。